Source:http://linkedlifedata.com/resource/pubmed/id/11369168
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-5-22
|
pubmed:abstractText |
Liver disease is frequent in patients taking home parenteral nutrition (HPN), but its cause remains unclear. Ongoing inflammation was implicated in HPN-associated cholestasis, so we examined the relation between liver-enzyme concentrations and circulating inflammatory and immune markers in these patients. In 17 HPN patients and 10 age- and sex-matched control subjects, we examined erythrocyte sedimentation rate, blood neopterin, soluble interleukin (IL)--2 receptors, circulating tumor necrosis factor-alpha, IL-6, aspartate and alanine aminotransferases, alkaline phosphatases, and gamma-glutamyltranspeptidase (GGT) concentrations. Fourteen of 17 patients had abnormal liver function tests with an increase in alkaline phosphatases (P < 0.001), gamma-glutamyltranspeptidase (P < 0.01), and aspartate aminotransferase (P < 0.01). Alkaline phosphatases were positively correlated to erythrocyte sedimentation rate, neopterin, tumor necrosis factor-alpha, and IL-6. gamma-Glutamyltranspeptidase was positively linked to tumor necrosis factor-alpha and soluble IL-2 receptors. There was no link between aminotransferases and inflammatory parameters. Liver-enzyme concentrations were correlated to the amount of total intravenous calories and calories originating from carbohydrates but not to infused lipids (median infused lipids x kg(-1) body weight x d(-1) = 0.62 g) in contrast to recently published data. Our results confirmed that the number of infused calories contributes to liver toxicity in HPN patients and strongly suggested that sustained inflammation is probably a key factor in worsening HPN-associated cholestasis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0899-9007
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
300-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11369168-Adult,
pubmed-meshheading:11369168-Aged,
pubmed-meshheading:11369168-Biological Markers,
pubmed-meshheading:11369168-Blood Sedimentation,
pubmed-meshheading:11369168-Case-Control Studies,
pubmed-meshheading:11369168-Cholestasis,
pubmed-meshheading:11369168-Cytokines,
pubmed-meshheading:11369168-Female,
pubmed-meshheading:11369168-Humans,
pubmed-meshheading:11369168-Liver,
pubmed-meshheading:11369168-Liver Diseases,
pubmed-meshheading:11369168-Liver Function Tests,
pubmed-meshheading:11369168-Male,
pubmed-meshheading:11369168-Middle Aged,
pubmed-meshheading:11369168-Neopterin,
pubmed-meshheading:11369168-Parenteral Nutrition, Home,
pubmed-meshheading:11369168-Tumor Necrosis Factor-alpha
|
pubmed:year |
2001
|
pubmed:articleTitle |
Persistent inflammation and immune activation contribute to cholestasis in patients receiving home parenteral nutrition.
|
pubmed:affiliation |
Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, Centre Agréé de Nutrition Parentérale à Domicile, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg, France. jean-marie.reimund@chru-strasbourg.fr
|
pubmed:publicationType |
Journal Article
|